Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

17.01

-0.54 (-3.08%)

At close: May 18, 2026, 4:00 PM EDT

17.14

+0.13 (0.77%)

Pre-market: May 19, 2026, 7:43 AM EDT

Sarepta Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,796	2,259	11,782	9,039	11,397	7,846
Market Cap Growth	-70.86%	-80.83%	30.35%	-20.69%	45.26%	-42.02%
Enterprise Value	2,190	2,348	11,757	8,636	11,009	6,868
Last Close Price	17.01	21.52	121.59	96.43	129.58	90.05
PE Ratio	26.68	-3.02	51.96	-16.63	-16.14	-17.49
Forward PE	19.68	90.12	15.47	-	-	-
PS Ratio	0.82	1.03	6.19	7.27	12.21	11.18
PB Ratio	1.19	1.98	7.71	10.52	29.61	8.45
P/TBV Ratio	1.23	1.89	8.59	10.37	29.47	7.89
P/FCF Ratio	15.63	-7.35	-34.38	-15.66	-32.00	-16.29
P/OCF Ratio	10.25	-10.99	-57.25	-18.04	-35.03	-17.70
EV/Sales Ratio	1.00	1.07	6.18	6.95	11.80	9.79
EV/EBITDA Ratio	47.41	-3.58	49.95	-34.44	-22.27	-16.29
EV/EBIT Ratio	2091.41	-3.35	53.91	-32.24	-20.53	-14.94
EV/FCF Ratio	19.06	-7.64	-34.30	-14.96	-30.91	-14.26
Debt / Equity Ratio	0.69	0.90	0.87	1.48	4.16	1.23
Debt / EBITDA Ratio	248.30	-1.57	5.65	-5.50	-3.27	-2.70
Debt / FCF Ratio	-1.62	-3.34	-3.88	-2.39	-4.54	-2.36
Net Debt / Equity Ratio	0.26	0.08	-0.02	-0.35	-0.97	-1.05
Net Debt / EBITDA Ratio	91.85	-0.13	-0.11	1.19	0.75	2.32
Net Debt / FCF Ratio	-0.60	-0.29	0.07	0.52	1.04	2.03
Asset Turnover	0.67	0.60	0.53	0.39	0.30	0.23
Inventory Turnover	0.85	1.01	0.59	0.57	0.72	0.46
Quick Ratio	2.10	1.22	2.67	3.18	3.56	5.01
Current Ratio	4.63	2.32	4.20	3.95	4.13	5.75
Return on Equity (ROE)	4.92%	-53.47%	19.71%	-86.15%	-107.16%	-49.57%
Return on Assets (ROA)	-3.34%	-19.44%	5.44%	-8.63%	-17.42%	-14.99%
Return on Invested Capital (ROIC)	-5.55%	-37.52%	12.58%	-31.86%	-83.61%	-64.49%
Return on Capital Employed (ROCE)	-1.66%	-25.51%	7.47%	-10.46%	-20.61%	-17.47%
Earnings Yield	3.62%	-33.13%	1.92%	-6.01%	-6.20%	-5.72%
FCF Yield	6.40%	-13.61%	-2.91%	-6.38%	-3.13%	-6.14%
Buyback Yield / Dilution	-10.78%	7.19%	-16.75%	-5.53%	-7.75%	-4.24%
Total Shareholder Return	-10.78%	7.19%	-16.75%	-5.53%	-7.75%	-4.24%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q